MODERATE HEREDITARY FACTOR VIII DEFICIENCY DISEASE WITHOUT INHIBITOR

Clinical trials for MODERATE HEREDITARY FACTOR VIII DEFICIENCY DISEASE WITHOUT INHIBITOR explained in plain language.

Never miss a new study

Get alerted when new MODERATE HEREDITARY FACTOR VIII DEFICIENCY DISEASE WITHOUT INHIBITOR trials appear

Sign up with your email to follow new studies for MODERATE HEREDITARY FACTOR VIII DEFICIENCY DISEASE WITHOUT INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New preventive treatment shows promise for reducing bleeds in hemophilia a

Disease control Completed

This study tested a preventive treatment called emicizumab in people with mild or moderate hemophilia A who do not have inhibitors. The goal was to see if regular injections could safely reduce the number of bleeding episodes. Researchers measured how often participants bled and …

Matched conditions: MODERATE HEREDITARY FACTOR VIII DEFICIENCY DISEASE WITHOUT INHIBITOR

Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

MODERATE HEREDITARY FACTOR VIII DEFICIENCY DISEASE WITHOUT INHIBITOR

Get alerted when new MODERATE HEREDITARY FACTOR VIII DEFICIENCY DISEASE WITHOUT INHIBITOR trials appear

New preventive treatment shows promise for reducing bleeds in hemophilia a